![]() ![]() Knowledge of the components is important to help identify potential COVID-19 patients and properly treat complications.ĬOVID-19 Coronavirus Dermatology Emergency medicine SARS-CoV-2 Skin.Ĭopyright © 2020 Elsevier Inc. These rashes will typically go away on their own in 212 days. It may look similar to hives, chickenpox, chilblains, or measles. It is important to be aware of the dermatologic manifestations and complications of COVID-19. A COVID-19 rash in adults can vary in appearance. While most of these dermatologic findings are self-resolving, they can help increase one's suspicion for COVID-19. These include maculopapular rashes, urticaria, vesicles, petechiae, purpura, chilblains, livedo racemosa, and distal limb ischemia. There are several types of skin findings described in association with COVID-19. The primary etiologies include vasculitis versus direct viral involvement. This brief report summarizes the dermatologic manifestations and complications associated with COVID-19 with an emphasis on Emergency Medicine clinicians.ĭermatologic manifestations of COVID-19 are increasingly recognized within the literature. While much of the focus has been on the cardiac and pulmonary complications, there are several important dermatologic components that clinicians must be aware of. As a potential correlate to disease severity, prognosis, or infectibility, it is critical that all healthcare professionals be well versed in these increasingly common cutaneous manifestations of COVID-19.The novel coronavirus disease of 2019 (COVID-19) is associated with significant morbidity and mortality. ![]() Discussion Dermatologic manifestations of COVID-19 are increasingly recognized within the literature. Vesicular rashes may suggest an initial diagnosis of COVID-19, acral lesions may be most appropriate for epidemiological uses, and vascular rashes may be a useful prognostic marker for severe disease. Objective This brief report summarizes the dermatologic manifestations and complications associated with COVID-19 with an emphasis on Emergency Medicine clinicians. Erythema multiforme-like eruptions, although infrequent (3.7% of cases), affected mostly children (mean age, 12.2 years). Vascular rashes resembling livedo or purpura were uncommon (4% of cases), appearing in elderly patients (mean age, 77.5 years) and occurring at the same time as non-cutaneous COVID-19 symptoms (18/29 patients). Urticarial rashes affected 10.9% of patients, appearing in adults (mean age, 38.3 years) and occurring at the same time as non-cutaneous symptoms (46/78 patients). Vesicular rashes affected 13.0% of patients, appearing in middle-aged adults (mean age, 48.3 years) after the onset of other symptoms (52/84 patients). Erythematous maculopapular rashes affected 21.3% of patients, most frequently impacting middle-aged adults (mean age, 53.2 years) and occurring at the same time as non-cutaneous symptoms (110/187 patients). Acral lesions resembling pseudo-chilblains were the most frequent lesion identified (40.4% of cases), appearing in young adults (mean age, 23.2 years) after the onset of extracutaneous COVID-19 symptoms (55/100 patients). Case reports (n = 15), case series (n = 13), and observational prospective studies (n = 4) were the most common publication types. The literature search identified 115 records, of which 34 publications describing 996 patients with dermatologic conditions were included. The aim of this review was to collate and categorize the dermatologic findings reported in patients with COVID-19 and identify specific lesions that may facilitate diagnosis and prognostication.Īn evidence-based review of the PubMed database was conducted on 14 May, 2020 using the search terms "Covid-19 skin," "Covid-19 rash," "Covid-19 exanthem," and "Covid-19 chilblains." Peer-reviewed publications containing original COVID-19 patient cases and a discussion of the associated cutaneous findings were included in the analysis. The severity of a COVID-19 case is associated with different types of skin symptoms. ![]() Although this virus primarily causes respiratory symptoms, an increasing number of cutaneous manifestations associated with this disease have been reported. Fajrul Islam / Getty Images Key Takeaways COVID-19 long-haulers can experience skin symptoms, like hives and COVID toes, which can last for months, new research has found. The coronavirus disease 2019 (COVID-19) pandemic has affected 18 million people and killed over 690,000 patients. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |